Horizon Kinetics Medical ETF Rating $27.25 +0.24 (+0.89%) (As of 11/20/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrends Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.67Holdings in MEDX have an aggregate rating of Moderate Buy based on 422 analyst ratings issued in the past year covering 31 companies (87.5% of the portfolio).MEDX Aggregate Price Target$27.25High Prediction$27.25Average Prediction$27.25Low Prediction$27.25Holdings in MEDX have an aggregate price target of $27.25 and a range of $27.25 to $27.25 covering 31 companies (87.5% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.03%LLYEli Lilly and Company$753.41+3.2%4.9914 of 5 stars2.81$1,007.94 33.8%21Positive News9.00%ABBVAbbVie$167.74+0.7%4.9604 of 5 stars2.90$203.37 21.2%21Analyst ForecastPositive News6.18%AMGNAmgen$287.87+2.8%4.908 of 5 stars2.46$333.57 15.9%26Ex-DividendShort Interest ↓5.69%BMYBristol-Myers Squibb$57.88-0.6%4.7747 of 5 stars2.20$54.07 -6.6%20Analyst Revision5.10%AZNAstraZeneca$63.20-0.9%3.9736 of 5 stars2.92$89.75 42.0%12Analyst UpgradeAnalyst Revision4.69%JNJJohnson & Johnson$153.10+0.1%4.9618 of 5 stars2.53$175.94 14.9%15Positive News4.41%ALNYAlnylam Pharmaceuticals$248.79+6.2%4.3868 of 5 stars2.71$298.09 19.8%24Analyst Forecast4.22%PFEPfizer$24.95-0.6%5 of 5 stars2.50$32.92 32.0%16Analyst DowngradeAnalyst Revision3.95%MRKMerck & Co., Inc.$97.43+0.9%4.9964 of 5 stars2.68$130.86 34.3%19Dividend IncreasePositive News3.47%REGNRegeneron Pharmaceuticals$743.35-0.2%4.786 of 5 stars2.78$1,099.55 47.9%233.40%ALKSAlkermes$27.91+1.6%4.7788 of 5 stars2.58$35.42 26.9%12Positive News3.12%BIIBBiogen$156.00+0.4%4.8601 of 5 stars2.54$258.96 66.0%28Analyst Downgrade2.82%CRSPCRISPR Therapeutics$47.26+0.6%1.771 of 5 stars2.37$74.94 58.6%192.75%IONSIonis Pharmaceuticals$35.40+4.9%4.2197 of 5 stars2.68$60.65 71.3%192.38%GSKGSK$33.36-0.3%4.4031 of 5 stars2.60$43.25 29.6%10Options Volume1.94%BCYCBicycle Therapeutics$20.36-0.6%2.8495 of 5 stars2.78$40.13 97.1%9Analyst Revision1.21%BEAMBeam Therapeutics$24.49-3.2%2.9185 of 5 stars2.75$44.91 83.4%121.18%NTLAIntellia Therapeutics$13.12-7.1%4.5239 of 5 stars2.72$54.94 318.7%18Analyst Forecast0.97%REPLReplimune Group$11.23+2.6%4.2366 of 5 stars3.17$16.80 49.6%60.78%HLNHaleon$9.50+0.1%4.0103 of 5 stars3.00$10.95 15.3%6Positive News0.76%GALTGalectin Therapeutics$2.82+2.2%1.7002 of 5 stars3.00$11.00 290.8%1Analyst UpgradeAnalyst RevisionNews Coverage0.69%VNDAVanda Pharmaceuticals$4.90-0.4%4.4313 of 5 stars3.00$15.50 216.3%20.53%EDITEditas Medicine$2.41-2.8%4.7809 of 5 stars2.54$9.08 276.9%13Short Interest ↓0.52%LTRNLantern Pharma$2.94-4.5%1.5019 of 5 stars2.001Positive NewsGap Down0.48%GEHCGE HealthCare Technologies$84.90+2.9%4.447 of 5 stars2.60$94.36 11.1%15Options VolumePositive News0.43%TSVT2seventy bio$3.11-3.4%2.4533 of 5 stars2.56$9.00 189.4%90.28%ALLOAllogene Therapeutics$2.05-3.3%2.7811 of 5 stars2.75$9.73 374.8%12Short Interest ↓0.24%VTRSViatris$13.13+0.6%1.3448 of 5 stars2.00$13.33 1.5%30.14%PACBPacific Biosciences of California$1.721.846 of 5 stars2.47$3.63 110.8%15Analyst Revision0.10%BLUEbluebird bio$0.302.8596 of 5 stars2.00$3.03 898.3%11Analyst Forecast0.05%MURAMural Oncology$3.373.191 of 5 stars3.25$16.00 374.8%4Analyst Revision This page (NASDAQ:MEDX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
